HealthTech companies: communication that builds trust with hospital buyers before your first deployment
A hospital CIO won't deploy a medical AI solution from an unknown vendor. A doctor won't prescribe a device they've never heard of. A health insurance provider won't fund a digital health solution without signs of institutional credibility. Linker builds the communication strategy that establishes your HealthTech as a recognized authority in medical and tech media before your sales teams even make contact.

4000+
500+
250+
Communication challenges for HealthTech solutions in 2026
Healthcare is the tech sector where every word carries responsibility. Where the buyers who decide are not the ones who use the product. Where regulatory milestones are communication opportunities that almost no one seizes. Founders who master this complexity outpace their competitors on every front.
Breaking through the trust barrier with hospital buyers
Hospital IT directors, department heads, and medical boards have long, demanding, and collective procurement processes. They do not take risks on unknown vendors when it comes to medical information systems or clinical decision support tools. A founder who is visible in industry publications like Hospimedia or TICsanté enters the sales cycle with trust already partially established: it is a direct commercial advantage.
Turning regulatory milestones into moments of credibility
Securing PECAN, CE MDR marking, a favorable HAS assessment, or HDS certification are milestones that most HealthTech founders fail to leverage in their communications. Yet, these are the most powerful signals of trust for hospitals, insurers, and investors. Every regulatory milestone is a high-impact communication opportunity waiting to be orchestrated.
Communicating without overstepping what science proves
HealthTech is the only tech sector where communication is directly governed by medical law, health-related GDPR, and professional medical ethics. You cannot claim a cure without clinical proof. You cannot promise a diagnosis without validation. Founders who master this precise, rigorous, and credible tone are seen as trusted partners, whereas others trigger rejection.
Speaking to prescribers and payers with two consistent narratives
The doctor prescribing your solution and the insurance provider or hospital funding it have different expectations. The former wants clinical proof and seamless workflow integration. The latter wants a measurable ROI, regulatory compliance, and a credible reimbursement model. Linker structures these two parallel narratives so they reinforce rather than contradict each other.
Raising funds in a more selective market
HealthTech funds are more demanding in 2026: venture capital is focusing on players with a credible reimbursement path and measurable initial clinical deployments. A founder who is visible in Les Echos and BuzzeSanté, with a precise narrative regarding their path to PECAN or HAS, enters a funding round with a decisive advantage over companies that haven't yet worked on their visibility.
Recruiting rare biomedical talent
Biomedical engineers, health-specialized data scientists, and product managers with a clinical background are among the rarest profiles in the entire tech ecosystem. They choose their employers based on the mission and the founder's public reputation. A founder who is visible in the health and tech press attracts these profiles, who don't wait for a job posting to reach out.
Where healthcare professionals stay informed and investors evaluate your credibility
Hospital CIOs read Hospimedia before shortlisting a vendor. Doctors follow What's up Doc and their peers on LinkedIn. Healthcare funds and analysts follow Les Echos and BuzzeSanté. Linker builds your presence across all these platforms simultaneously, with a message tailored to each audience in the healthcare ecosystem.
LinkedIn to engage your prospects, investors, and talent every day.
The French sales community is by far the most active on LinkedIn. Your buyers use it to stay informed, seek recommendations, and build their shortlists before they even open a tender. Linker positions SalesTech founders as the thought leaders the sales community follows (agentic AI, signal orchestration, social selling, revenue intelligence) ahead of every purchasing decision.

Public Relations
Public Relations to establish your legitimacy in the media that matters.
An op-ed in Action Co or an interview in Les Echos builds a level of credibility with your buyers and investors that LinkedIn cannot achieve alone. Linker places SalesTech companies in the media actually read by sales directors, CROs, and active sector investors, with angles rooted in real market debates.

Two levers working together for greater impact
In SalesTech, reputation is built within the community before it is built in the media. LinkedIn fuels your buyers' daily market intelligence and keeps your name circulating in their conversations. The press establishes the legitimacy that turns that awareness into institutional credibility. Together, they create the influence system that makes you the founder the sales community recommends and investors recognize.
Startups & scale-ups supported by Linker














































The moments when HealthTech communication changes the commercial trajectory
Your journey as a HealthTech founder always has a story to tell. Securing PECAN or CE marking, a first deployment in a university hospital, or a clinical publication that validates your approach. These milestones build your credibility, provided you transform them into media statements at the right time and through the right channels.
Demonstrate that a SalesTech founder knows how to sell their vision
Funds investing in SalesTech expect proof that the founder knows how to sell what they are building. Linker deploys a LinkedIn strategy rooted in your vertical (agentic AI, signal orchestration, social selling, revenue intelligence) so that you embody a perspective recognized by the community. In parallel, we secure op-eds in outlets like Les Echos or Action Co so that investors have already associated your name with expertise before you send your first email.
Establish your perspective on the next generation of B2B sales
Securing PECAN, CE MDR marking, a favorable HAS assessment, or HDS certification is equivalent to a funding round in terms of the impact on buyer confidence. Yet, almost all HealthTech founders communicate too little or too poorly about these milestones. Linker orchestrates the media moment: a tailored angle for Hospimedia and TICsanté, a coordinated founder post on LinkedIn, and a press release targeted at investors and industrial partners. The regulatory milestone becomes a commercial event.
The HealthTech founder as a reference recommended by healthcare professionals
University hospitals and healthcare facilities operate as a network: a CIO who has successfully deployed your solution talks about it to their peers at the HIT congress or in professional associations. Linker builds the visibility that accelerates this institutional word-of-mouth: a founder known in Hospimedia is recommended in hospital circles without having to prospect. At the same time, the rare biomedical profiles you are looking for join a project whose clinical vision they are already familiar with.
Are you preparing for a fundraising round, your PECAN application, or your deployment in healthcare facilities?
30 minutes to analyze your position in the HealthTech ecosystem, understand your goals, and define the communication levers that make sense for your clinical and commercial stage. Based in Paris, we work with HealthTech startups all over France.

What Linker builds for HealthTech scale-ups
We work exclusively with tech startups and scale-ups. We know HealthTech, its medical buyers, and its regulatory constraints. It is this dual clinical and commercial perspective that allows us to position your founders as credible references in the eyes of hospital CIOs, healthcare professionals, and specialized funds.
SalesTech vertical expertise
PECAN, MDR CE marking, HAS, HDS certification, health GDPR, DMP and ENS interoperability: no need to explain your environment to us. We understand the challenges of hospital buyers, the constraints of medical professions, and the arguments that make the difference.
2 combined areas of expertise
You master the science and clinical aspects; we master LinkedIn and PR. We know how to build a narrative that convinces a department head of the clinical value, a hospital CIO of the integration and compliance, and a fund of the path to reimbursement. Three audiences, one consistent editorial thread.
SalesTech media network
Long-term relationships with journalists covering digital health, MedTech, and hospital innovation in France. Your clinical and regulatory milestones reach the right contacts, with the angles that interest each publication and each buyer segment.
Full delegation or guided support
Do you prefer to delegate entirely or stay in the driver's seat? Linker adapts to both LinkedIn and PR. The goal remains the same: to make you the HealthTech founder that healthcare professionals and investors identify as the benchmark in your segment.
Startup founders who built their credibility with Linker
Founders whose PECAN approval generated inbound requests from hospital CIOs. HealthTech leaders positioned as medical AI experts before their Series A. Startups where department heads talk to their peers before the sales team has even reached out.
Our services to stand out in the HealthTech ecosystem
LinkedIn to occupy space within the medical and digital health community and create daily social proof among healthcare professionals. The press to establish your legitimacy with hospital buyers and investors over the long term. Together, they create the influence system that transforms HealthTech founders into benchmarks in their clinical segment.
Discover the services of our LinkedIn and Public Relations (PR) agency in Paris.
LinkedIn Agency
To engage your prospects, investors, and talent.
Ghostwriting, content strategy, personal branding: Linker builds your LinkedIn presence within your HealthTech vertical. Medical AI, digital health, health data, telemedicine, digital therapeutics, interoperability. We structure the angles that resonate with healthcare professionals and hospital decision-makers, writing with the medical rigor your sector demands.

Public Relations Agency
To establish your legitimacy in the media that matters.
Tailor-made journalist pitches, opinion pieces, press releases: Linker positions you in Hospimedia, TICsanté, What's up Doc, and Les Echos on the topics driving your market. Responsible medical AI, PECAN and digital health reimbursement, interoperability, transformation of the care pathway. Each piece of coverage serves a specific objective.

What HealthTech startups ask us before getting started
Healthcare is the most regulated and evidence-demanding tech sector. Industry experts have specific questions about what they can say, how to build credibility that survives the scrutiny of medical buyers, and how to leverage their regulatory milestones in their communications.
By working within the framework of improving the care pathway, not making therapeutic promises. We don't cure, we don't diagnose; we reduce treatment time, improve the precision of surgical procedures, and facilitate access to care. This precise framing is both a regulatory constraint and a signal of credibility for medical buyers. Linker builds this narrative with you: rigorous in substance, impactful in form, and commercially actionable without legal exposure.
Yes, and much more than most HealthTech founders think. Innovative doctors, hospital digital directors, and healthcare innovation managers follow debates on LinkedIn regarding medical AI, health data, and the transformation of the healthcare system. A HealthTech founder who takes a rigorous stance on these topics is identified as a serious contact before any commercial process begins. This is especially true for reaching hospital doctors who do not read the tech press but have an active professional presence on LinkedIn.
By treating it like a fundraising round in terms of media impact. Obtaining PECAN means that the HAS recognizes the potential value of your solution and paves the way for reimbursement: it is a signal of credibility unmatched for hospitals and insurers. The CE MDR marking certifies your device's compliance with the strictest European standards. Linker orchestrates these moments: a press angle targeted at hospital media, a founder's LinkedIn post, and a press release for funds and industrial partners. A technical milestone becomes a commercial event.
It depends on your objective. To reach CIOs and hospital decision-makers: Hospimedia, TICsanté, DeviceMed. For prescribing physicians: What's up Doc, BuzzeSanté. For fundraising and the startup ecosystem: Les Echos, Maddyness. For the general public and patient trust: Le Monde Santé, France Info Santé. No generalist distribution, only the outlets that matter for your HealthTech segment and your commercial goals.
HIT is the annual congress for digital health decision-makers. The HealthTech Awards are organized by France Biotech. In both cases, visibility must be prepared in advance so you arrive with established notoriety. Linker builds your presence in Hospimedia and TICsanté before these events, positions your LinkedIn profile on conference topics, and organizes your speaking engagements so that CIOs and healthcare professionals know you before they meet you on-site.
A senior ghostwriter writes and publishes your LinkedIn posts, anchored in the clinical and regulatory issues of your HealthTech vertical. A PR consultant builds your relationships with journalists at Hospimedia, TICsanté, and the business press, pitching your angles at the right time, especially during your regulatory milestones. Both work in coordination. On your end: a 30-minute call per month. One single point of contact, one coherent strategy.
Yes, provided you have a clear positioning on your clinical segment and a point of view to defend regarding the transformation of your healthcare field. At the early stage, LinkedIn is particularly effective: building the founder's credibility within the medical community early on is less costly than trying to catch up before a fundraising round or a hospital tender. PR can start with expert angles: taking a stance on responsible medical AI, analyzing the challenges of PECAN, or writing op-eds on the digital transformation of the care pathway. Even before you have a certification or your first major account.







